We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$726B
AUM Growth
+$72B
Cap. Flow
+$18.3B
Cap. Flow %
2.52%
Top 10 Hldgs %
22.02%
Holding
4,790
New
331
Increased
3,384
Reduced
720
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 13.87%
3 Healthcare 13.39%
4 Consumer Discretionary 11.81%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CFB
2376
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$11.3M ﹤0.01%
822,384
-300
-0% -$4.33K
UEIC icon
2377
Universal Electronics
UEIC
$60.9M
$11.3M ﹤0.01%
232,849
+7,042
+3% +$365K
KRON
2378
DELISTED
Kronos Bio
KRON
$11.3M ﹤0.01%
471,023
+202,103
+75% +$5.12M
WTRE
2379
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
$11.3M ﹤0.01%
321,698
+4,212
+1% +$147K
NPTN
2380
DELISTED
NEOPHOTONICS CORP
NPTN
$11.2M ﹤0.01%
1,098,940
+26,738
+2% +$282K
FFIC
2381
DELISTED
Flushing Financial
FFIC
$11.2M ﹤0.01%
521,143
+16,581
+3% +$375K
NIC icon
2382
Nicolet Bankshares
NIC
$3.68B
$11.2M ﹤0.01%
158,706
-2,776
-2% -$216K
KOP icon
2383
Koppers
KOP
$981M
$11.2M ﹤0.01%
344,967
+13,581
+4% +$458K
CTBI icon
2384
Community Trust Bancorp
CTBI
$1.44B
$11.1M ﹤0.01%
275,539
-2,369
-0.9% -$104K
CRIS icon
2385
Curis
CRIS
$9.34M
$11.1M ﹤0.01%
3,447
+1,781
+107% +$8.05M
FMTX
2386
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$11.1M ﹤0.01%
446,647
+13,360
+3% +$359K
CMRX
2387
DELISTED
Chimerix, Inc.
CMRX
$11.1M ﹤0.01%
1,387,641
+136,763
+11% +$1.14M
FMBH icon
2388
First Mid Bancshares
FMBH
$1.4B
$11.1M ﹤0.01%
273,444
+25,237
+10% +$1.09M
AKBA icon
2389
Akebia Therapeutics
AKBA
$354M
$11.1M ﹤0.01%
2,922,652
+323,845
+12% +$1.09M
KREF
2390
KKR Real Estate Finance Trust
KREF
$464M
$11.1M ﹤0.01%
511,913
+46,260
+10% +$969K
ANIK icon
2391
Anika Therapeutics
ANIK
$255M
$11M ﹤0.01%
255,050
+12,637
+5% +$538K
IIIV icon
2392
i3 Verticals
IIIV
$421M
$11M ﹤0.01%
364,133
+40,660
+13% +$1.29M
GOGO icon
2393
Gogo Inc
GOGO
$629M
$11M ﹤0.01%
965,315
+77,889
+9% +$901K
PETS icon
2394
PetMed Express
PETS
$42.3M
$11M ﹤0.01%
344,575
+5,640
+2% +$179K
CIR
2395
DELISTED
CIRCOR International, Inc
CIR
$11M ﹤0.01%
336,582
-8,917
-3% -$315K
ARDX icon
2396
Ardelyx
ARDX
$1.22B
$10.9M ﹤0.01%
1,444,398
+159,076
+12% +$1.18M
EAR
2397
DELISTED
Eargo, Inc. Common Stock
EAR
$10.9M ﹤0.01%
13,712
+4,574
+50% +$3.83M
HWKN icon
2398
Hawkins
HWKN
$2.8B
$10.9M ﹤0.01%
334,048
+2,253
+0.7% +$74.6K
DQ
2399
Daqo New Energy
DQ
$907M
$10.9M ﹤0.01%
169,666
+12,662
+8% +$910K
CNXN icon
2400
PC Connection
CNXN
$2.21B
$10.9M ﹤0.01%
235,124
+6,265
+3% +$294K

Similar funds

Geode Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
  • Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
  • Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
  • Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
  • Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
  • Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.